Mankind Pharma fundamental analysis

MANKIND

2017.7

19.20 (0.96%)
Last updated on 6 Apr, 2026 | 15:55 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Mankind Pharma Fundamentals

P/E Ratio

46.34

P/B Ratio

5.25

Div. Yield

0

Sector P/E

60.59

Sector P/B

3.25

Sec. Div. Yield

0.59

Mankind Pharma Fundamentals is currently trading with a P/E Ratio of 46.34, compared to the sector average of 60.59. Its P/B Ratio stands at 5.25, while the sector’s is 3.25. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.59%.

Mankind Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Mankind Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost